LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells

BACKGROUND: Although promising for graft-versus-host disease (GvHD) treatment, MSC therapy still faces important challenges. For instance, increasing MSC migratory capacity as well as potentializing immune response suppression are of interest. For GvHD management, preventing opportunistic infections...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Stem Cell Res Ther
Päätekijät: Oliveira-Bravo, Martha, Sangiorgi, Bruno Braga, Schiavinato, Josiane Lilian dos Santos, Carvalho, Juliana Lott, Covas, Dimas Tadeu, Panepucci, Rodrigo Alexandre, Neves, Francisco de Assis Rocha, Franco, Octávio Luiz, Pereira, Rinaldo Wellerson, Saldanha-Araujo, Felipe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203704/
https://ncbi.nlm.nih.gov/pubmed/28038684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0448-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia